Trial
NCT04682249
Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
ICC
Intervention
Systemic Chemotherapy
Why stopped
no patients enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-04